UK cancer mutation testing firm Biofidelity raises $12mCambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect Share XUK cancer mutation testing firm Biofidelity raises $12mhttps://pharmaphorum.com/news/uk-cancer-mutation-testing-firm-biofidelity-raises-12m/
